Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares Outstanding
Ratios

United Health Products (UEEC) EBIAT (2016 - 2025)

United Health Products' EBIAT history spans 15 years, with the latest figure at -$536908.0 for Q4 2025.

  • Quarterly results put EBIAT at -$536908.0 for Q4 2025, up 34.05% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (down 33.35% YoY), and the annual figure for FY2025 was -$2.7 million, down 33.35%.
  • EBIAT for Q4 2025 was -$536908.0 at United Health Products, down from -$285594.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $820567.0 in Q3 2022 to a low of -$27.0 million in Q1 2021.
  • The 5-year median for EBIAT is -$600837.5 (2022), against an average of -$2.0 million.
  • The sharpest move saw EBIAT tumbled 4221.86% in 2021, then surged 213.27% in 2022.
  • Year by year, EBIAT stood at -$1.5 million in 2021, then surged by 54.87% to -$664767.0 in 2022, then grew by 29.01% to -$471918.0 in 2023, then crashed by 72.51% to -$814112.0 in 2024, then surged by 34.05% to -$536908.0 in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$536908.0, -$285594.0, and -$315187.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.